References
- Trabert B, Holt VL, Yu O, et al. Population-based ectopic pregnancy trends, 1993–2007. Am J Prev Med 2011;40:556–60
- Ectopic pregnancy mortality – Florida, 2009–2010. MMWR Morb Mortal Wkly Rep 2012;61:106–9
- Thia EWH, Loi K, Wang JJ, Siow A. Methotrexate treatment for ectopic pregnancy at the KK Women's and Children's Hospital, Singapore. Singapore Med J 2009;50:1058–61
- Bachman EA, Barnhart K. Medical management of ectopic pregnancy: a comparison of regimens. Clin Obstet Gynecol 2012;55:440–7
- Kopani F, Rrugia A, Manoku N. Ectopic pregnancy comparison of different treatments. J Prenat Med 2010;4:30–4
- Beall S, DeCherney AH. Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility. Fertil Steril 2012;98:1118–20
- Clark LE, Bhagavath B, Wheeler CA, et al. Role of routine monitoring of liver and renal function during treatment of ectopic pregnancies with single-dose methotrexate protocol. Fertil Steril 2012;98:84–8
- Stika CS. Methotrexate: the pharmacology behind medical treatment for ectopic pregnancy. Clin Obstet Gynecol 2012;55:433–9
- Skubisz MM, Tong S. The evolution of methotrexate as a treatment for ectopic pregnancy and gestational trophoblastic neoplasia: a review. ISRN Obstet Gynecol 2012;2012:637094. doi: 10.5402/2012/637094
- Kirk E, Condous G, Van Calster B, et al. A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy. Hum Reprod 2007;22:858–63
- Lipscomb GH, McCord ML, Stovall TG, et al. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 1999;341:1974–8
- Dhar H, Hamdi I, Rathi B. Methotrexate treatment of ectopic pregnancy: experience at nizwa hospital with literature review. Oman Med J 2011;26:94–8
- Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing “single dose” and “multidose” regimens. Obstet Gynecol 2003;101:778–84
- Guvendag Guven ES, Dilbaz S, Dilbaz B, et al. Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study. Acta Obstet Gynecol Scand 2010;89:889–95
- Kirk E, Bourne T. The nonsurgical management of ectopic pregnancy. Curr Opin Obstet Gynecol 2006;18:587–93
- Nowak-Markwitz E, Michalak M, Olejnik M, Spaczynski M. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy. Fertil Steril 2009;92:1203–7
- Rabischong B, Tran X, Sleiman AA, et al. Predictive factors of failure in management of ectopic pregnancy with single-dose methotrexate: a general population-based analysis from the Auvergne Register, France. Fertil Steril 2011;95:401–4
- van Mello NM, Mol F, Ankum WM, et al. Ectopic pregnancy: how the diagnostic and therapeutic management has changed. Fertil Steril 2012;98:1066–73
- van Mello NM, Mol F, Verhoeve HR, et al. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. Hum Reprod 2013;28:60–7
- Agostini A, Blanc K, Ronda I, et al. Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy. Fertil Steril 2007;88:504–6
- Gabbur N, Sherer DM, Hellmann M, et al. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy? Am J Perinatol 2006;23:193–6